Biosafety Level 5 (BSL-5)

There is no “Biosafety Level 5” (BSL-5) in the biosafety containment framework used in the United States. The CDC/NIH publication Biosafety in Microbiological and Biomedical Laboratories (BMBL, 6th edition, 2020) — the primary US reference for laboratory biosafety practice, and the framework incorporated by reference into the NIH Guidelines and the Federal Select Agent Program — defines exactly four cumulative containment levels, BSL-1 through BSL-4. BSL-4 is explicitly the maximum standard containment level: it is reserved for agents that pose a high risk of life-threatening disease, have no routinely available vaccine or treatment, and carry a realistic risk of aerosol transmission (for example Ebola, Marburg, and Variola/smallpox virus). No recognized national or international biosafety framework — including the frameworks referenced by WHO or by other countries’ biosafety authorities — defines a fifth, more stringent numbered tier above BSL-4. A search for “BSL-5” or “Biosafety Level 5” almost always reflects one of three things: (1) a misremembering or misreading of BSL-4 as if the numbering continued further; (2) informal or journalistic usage describing an especially dangerous, BSL-4-level pathogen as needing “level 5” containment for emphasis, with no formal designation behind the phrase; or (3) conflation of BSL-4’s two distinct primary-containment approaches — cabinet laboratories and suit laboratories — or of facility-specific “enhanced” protocols layered on top of baseline BSL-4 for a small number of especially high-consequence agents, as if these were a separate, higher-numbered level rather than variations within BSL-4 itself.

ByCASRAI Editorial Board

· Last updated 18 Jul 2026

Worked examples

Is an instance

A researcher drafting a grant budget justification writes "BSL-5 suite rental" when describing planned work with a filovirus — the correct terminology is BSL-4 (suit laboratory), since no BSL-5 designation exists to cite in the justification or in an IBC protocol submission.

Is an instance

A news article about an emerging pathogen states it "requires level 5 biocontainment" — read literally against BMBL, this is imprecise; the article almost certainly means BSL-4, the actual maximum defined level, possibly with facility-specific enhanced protocols layered on top.

Biosafety Level 5 (BSL-5) is not a real or recognized biosafety designation. The standard US biosafety containment framework — the CDC/NIH Biosafety in Microbiological and Biomedical Laboratories (BMBL, 6th edition, 2020) — defines four cumulative containment levels, BSL-1 through BSL-4, and stops there. BSL-4 is the maximum standard containment level currently defined for laboratory work with biological agents. This page exists because “Biosafety Level 5” is a search term people genuinely use, usually while trying to work out whether it is real — the short answer is no, and this page explains why the confusion arises and what the correct terminology actually is.

Why BSL-4 is the ceiling, not BSL-5

BMBL’s four levels are cumulative: each level layers additional practices, safety equipment, and facility engineering controls on top of the level below it, rather than replacing it. BSL-4 sits at the top of that stack because it is designed around the worst realistic case the framework addresses: agents that cause severe or fatal disease, for which no vaccine or treatment is routinely available, and where aerosol transmission is a credible exposure route (Ebola and Marburg virus are the commonly cited examples; Variola virus, which causes smallpox, is also handled at this level but is retained only at two WHO-authorized repositories rather than distributed to research laboratories generally). Because BSL-4 already assumes the most severe combination of risk factors the framework accounts for, there is no defined scenario in BMBL that a BSL-5 would exist to address — the containment measures BSL-4 requires (dedicated isolated facilities, redundant HEPA-filtered air handling, positive-pressure suits or Class III cabinet lines, mandatory decontamination showers) are already the maximum the standard specifies.

Where the “BSL-5” idea comes from

A few real, adjacent concepts likely feed the misconception:

BSL-4 has two different primary-containment approaches, which can read as if they were separate levels: a cabinet laboratory, where all agent work happens inside a gas-tight Class III biosafety cabinet, and a suit laboratory, where personnel work at an open bench wearing a full-body, positive-pressure, HEPA-filtered supplied-air suit with a mandatory chemical shower before exiting. Both are BSL-4 — neither is a higher numbered tier.
Institution- or agent-specific “enhanced” protocols are sometimes layered on top of baseline containment for a small number of especially high-consequence pathogens or procedures, at the discretion of an Institutional Biosafety Committee (IBC) or a funder. These enhancements are documented as BSL-3 “enhanced” or BSL-4-plus practice additions in institutional biosafety manuals, not as a new numbered level in BMBL itself.
Informal and media usage. Journalism, fiction, and casual conversation about outbreaks or bioterrorism sometimes reach for “level 5” to signal “worse than the worst officially defined category,” without the phrase corresponding to any actual regulatory or scientific designation.

Frequently asked questions

Is there a lab anywhere in the world officially rated BSL-5?

No. No national or international biosafety framework in current use — including the US CDC/NIH BMBL system referenced above — defines a fifth containment tier above BSL-4. If a facility is described elsewhere as “BSL-5,” that label is not being used in the formal BMBL sense.

What is the correct term for the highest level of lab biocontainment?

Biosafety Level 4 (BSL-4) is the correct, formally defined maximum containment level. Within BSL-4, “cabinet laboratory” and “suit laboratory” describe the two recognized primary-containment approaches.

Does “BSL-4 enhanced” mean the same thing as “BSL-5”?

No. Institution- or protocol-specific enhancements added on top of baseline BSL-4 (or, more commonly discussed, BSL-3 “enhanced” arrangements for select agents) are additional practices layered within the existing BMBL framework, decided by an Institutional Biosafety Committee, a funder, or the Federal Select Agent Program — they are not a distinct, separately numbered biosafety level.

Use in your systems

JATS XML <role> element

xml

<role vocab="credit"
      vocab-identifier="https://casrai.org/dictionary/"
      vocab-term="Biosafety Level 5 (BSL-5)"
      vocab-term-identifier="https://casrai.org/dictionary/term/biosafety-level-5-bsl-5" />

Schema.org DefinedTerm (JSON-LD)

json

{
  "@context": "https://schema.org",
  "@type": "DefinedTerm",
  "@id": "https://casrai.org/dictionary/term/biosafety-level-5-bsl-5",
  "name": "Biosafety Level 5 (BSL-5)",
  "identifier": "https://casrai.org/dictionary/term/biosafety-level-5-bsl-5",
  "description": "There is no “Biosafety Level 5” (BSL-5) in the biosafety containment framework used in the United States. The CDC/NIH publication Biosafety in Microbiological and Biomedical Laboratories (BMBL, 6th edition, 2020) — the primary US reference for laboratory biosafety practice, and the framework incorporated by reference into the NIH Guidelines and the Federal Select Agent Program — defines exactly four cumulative containment levels, BSL-1 through BSL-4. BSL-4 is explicitly the maximum standard containment level: it is reserved for agents that pose a high risk of life-threatening disease, have no routinely available vaccine or treatment, and carry a realistic risk of aerosol transmission (for example Ebola, Marburg, and Variola/smallpox virus). No recognized national or international biosafety framework — including the frameworks referenced by WHO or by other countries’ biosafety authorities — defines a fifth, more stringent numbered tier above BSL-4. A search for “BSL-5” or “Biosafety Level 5” almost always reflects one of three things: (1) a misremembering or misreading of BSL-4 as if the numbering continued further; (2) informal or journalistic usage describing an especially dangerous, BSL-4-level pathogen as needing “level 5” containment for emphasis, with no formal designation behind the phrase; or (3) conflation of BSL-4’s two distinct primary-containment approaches — cabinet laboratories and suit laboratories — or of facility-specific “enhanced” protocols layered on top of baseline BSL-4 for a small number of especially high-consequence agents, as if these were a separate, higher-numbered level rather than variations within BSL-4 itself.",
  "inDefinedTermSet": "https://casrai.org/dictionary/domain/compliance-regulatory#set",
  "url": "https://casrai.org/dictionary/term/biosafety-level-5-bsl-5",
  "sameAs": [],
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "publisher": {
    "@id": "https://casrai.org/#organization"
  },
  "dateModified": "2026-07-18T03:33:09",
  "inLanguage": "en"
}